共 6 条
[2]
Baseline glycemic parameters predict the hemoglobin A 1c response to DPP-4 inhibitors.[J].Katherine Esposito;Paolo Chiodini;Annalisa Capuano;Maria Ida Maiorino;Giuseppe Bellastella;Dario Giugliano.Endocrine.2014, 1
[3]
Safety and Efficacy of Sitagliptin Therapy for the Inpatient Management of General Medicine and Surgery Patients With Type 2 Diabetes.[J].Guillermo E. Umpierrez;Roma Gianchandani;Dawn Smiley;Sol Jacobs;David H. Wesorick;Christopher Newton;Farnoosh Farrokhi;Limin Peng;David Reyes;Sangeeta Lathkar-Pradhan;Francisco Pasquel.Diabetes Care.2013, 11
[4]
[6]
Dipeptidyl peptidase‐4 inhibitors in the treatment of type 2 diabetes: a comparative review.[J].C. F.Deacon.Diabetes; Obesity and Metabolism.2010, 1

